Keiko Esaki

1.2k total citations
11 papers, 543 citations indexed

About

Keiko Esaki is a scholar working on Molecular Biology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Keiko Esaki has authored 11 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Keiko Esaki's work include Hemophilia Treatment and Research (5 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Keiko Esaki is often cited by papers focused on Hemophilia Treatment and Research (5 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Keiko Esaki collaborates with scholars based in United States and Japan. Keiko Esaki's co-authors include Kunihiro Hattori, Tomoyuki Igawa, Tatsuhiko Tachibana, Tetsuhiro Soeda, Takehisa Kitazawa, Atsushi Muto, Kenta Haraya, Yoshiki Kawabe, Kazutaka Yoshihashi and Aya Harada and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Cancer.

In The Last Decade

Keiko Esaki

11 papers receiving 515 citations

Peers

Keiko Esaki
Aruna Gowda United States
M Schilling United States
Gaëlle Herledan United Kingdom
CR Faltynek United States
Ann Marie Blenc United States
Keiko Esaki
Citations per year, relative to Keiko Esaki Keiko Esaki (= 1×) peers Stefania Militi

Countries citing papers authored by Keiko Esaki

Since Specialization
Citations

This map shows the geographic impact of Keiko Esaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Esaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Esaki more than expected).

Fields of papers citing papers by Keiko Esaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiko Esaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Esaki. The network helps show where Keiko Esaki may publish in the future.

Co-authorship network of co-authors of Keiko Esaki

This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Esaki. A scholar is included among the top collaborators of Keiko Esaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Esaki. Keiko Esaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kitazawa, Takehisa, Keiko Esaki, Tatsuhiko Tachibana, et al.. (2017). Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens. Thrombosis and Haemostasis. 117(7). 1348–1357. 152 indexed citations
2.
Maeda, Atsuhiko, Yuki Iwayanagi, Kenta Haraya, et al.. (2017). Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody. mAbs. 9(5). 844–853. 16 indexed citations
3.
Kitamura, Hidetomo, Taichi Kuramochi, Yoshinobu Higuchi, et al.. (2016). Cynomolgus monkey model of interleukin‐31‐induced scratching depicts blockade of human interleukin‐31 receptor A by a humanized monoclonal antibody. Experimental Dermatology. 27(1). 14–21. 41 indexed citations
4.
Sampei, Zenjiro, Tomoyuki Igawa, Tetsuhiro Soeda, et al.. (2013). Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity. PLoS ONE. 8(2). e57479–e57479. 246 indexed citations
5.
Shiraishi, Takuya, Shojiro Kadono, Masayuki Haramura, et al.. (2010). Design and Synthesis of Peptidomimetic Factor VIIa Inhibitors. Chemical and Pharmaceutical Bulletin. 58(1). 38–44. 1 indexed citations
6.
Shiraishi, Takuya, Shojiro Kadono, Masayuki Haramura, et al.. (2009). Structure-Based Drug Design of Peptide Mimetics Containing Large P3 Moieties as Inhibitors of Factor VIIa. Letters in Drug Design & Discovery. 6(2). 86–92. 2 indexed citations
7.
Shiraishi, Takuya, Shojiro Kadono, Masayuki Haramura, et al.. (2008). Factor VIIa inhibitors: Target hopping in the serine protease family using X-ray structure determination. Bioorganic & Medicinal Chemistry Letters. 18(16). 4533–4537. 12 indexed citations
8.
Onuma, Etsuro, Koh Sato, Toshiaki Tsunenari, et al.. (2004). Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.. PubMed. 24(5A). 2665–73. 25 indexed citations
9.
Ohizumi, Iwao, Shin‐ichi Tsunoda, Kenji Taniguchi, et al.. (1998). Identification of tumor vascular antigens by monoclonal antibodies prepared from rat-tumor-derived endothelial cells. International Journal of Cancer. 77(4). 561–566. 13 indexed citations
10.
Ohizumi, Iwao, Shin‐ichi Tsunoda, Kenji Taniguchi, et al.. (1997). Antibody-Based Therapy Targeting Tumor Vascular Endothelial Cells Suppresses Solid Tumor Growth in Rats. Biochemical and Biophysical Research Communications. 236(2). 493–496. 13 indexed citations
11.
Orita, Tetsuro, Masayoshi Oh‐eda, Masakazu Hasegawa, et al.. (1994). Polypeptide and Carbohydrate Structure of Recombinant Human Interleukin-6 Produced in Chinese Hamster Ovary Cells. The Journal of Biochemistry. 115(2). 345–350. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026